Combined HTR2C-LEP and HTR2C-LEPR genotypes as a determinant for obesity in patients without antipsychotic drugs.

J Clin Psychopharmacol

Department of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht, the Netherlands and Department of Clinical Pharmacy Wilhelmina Hospital Assen Assen, the Netherlands Department of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht, the Netherlands and Department of Clinical Pharmacy Wilhelmina Hospital Assen Assen, the Netherlands Department of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht, the Netherlands and Department of Clinical Pharmacy University Medical Centre Utrecht Utrecht, the Netherlands Department of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht, the Netherlands and Department of Psychiatry Psychiatric Hospital Meerkanten Ermelo, the Netherlands Department of Internal Medicine Wilhelmina Hospital Assen Assen, the Netherlands Department of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht, the Netherlands and Department of Clinical Pharmacy University Medical Centre Utrecht Utrecht, the Netherlands.

Published: April 2014

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000069DOI Listing

Publication Analysis

Top Keywords

combined htr2c-lep
4
htr2c-lep htr2c-lepr
4
htr2c-lepr genotypes
4
genotypes determinant
4
determinant obesity
4
obesity patients
4
patients antipsychotic
4
antipsychotic drugs
4
combined
1
htr2c-lepr
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!